Eliprodil stimulates CNS myelination new prospects for multiple sclerosis?

Neurology

Volumn 52, Issue 2, 1999, Pages 346-350

  Demerens, Corinne ^a   Stankoff, Bruno ^a,b   Zalc, Bernard ^a   Lubetzki, Catherine ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ELIPRODIL; MICROTUBULE ASSOCIATED PROTEIN 2; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; NEUROPROTECTIVE AGENT; PROGESTERONE; SIGMA OPIATE RECEPTOR; THYROID HORMONE;

ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; FETUS; MOUSE; MULTIPLE SCLEROSIS; MYELINATION; NERVE CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION;

EID: 0033556445     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.2.346     Document Type: Article

References (30)

1. Pringle NP, Yu W-P, Guthrie S, et al. Determination of neuroepithelial cell fate: induction of the oligodendrocyte lineage by ventral midline cells and sonic hedgehog. Dev Biol 1996;177: 30-42.
2. Barres BA, Hart IK, Coles HSI, et al. Cell death and the control of cell survival in the oligodendrocyte lineage. Cell 1992;70:31-46.
3. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL. GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 1996;17:229-243.
4. Lubetzki C, Demerens C, Zalc B. Signaux axonaux de myélinisation dans le système nerveux central. Médecine/Sciences 1997;13:1097-1105.
5. Lubetzki C, Demerens C, Goujet-Zalc C, Anglade P, Zalc B. Even in vitro, oligodendrocytes myelinate solely axons. Proc Natl Acad Sci USA 1993;90:6820-6824.
6. Notterpek LM, Rome LH. Functional evidence for the role of axolemma in CNS myelination. Neuron 1994;13:473-485.
7. Macklin WB, Weill CL, Deininger PL. Expression of myelin proteolipid and basic protein mRNAs in culture cells. J Neurosci Res 1986;16:203-217.
8. Althaus HH, Montz H, Neuhoff V. Isolation and cultivation of mature oligodendroglia. Naturwissench 1984;71:309-315.
9. Demerens C, Stankoff B, Allinquant B, Couraud F, Zalc B, Lubetzki C. Induction of myelination in the central nervous system by electrical activity. Proc Natl Acad Sci USA 1996;93: 9887-9892.
10. Quirion R, Bowen WD, Itzhak Y, et al. A proposal for the classification of sigma binding sites. TIPS 1992;13:85-86.
11. De Coster MA, Klette KL, Knight ES, Tortella FC. σ Receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res 1995;671:45-53.
12. Silve S, Dupuy PH, Labit-Bouteiler C, et al. Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits d8-d7 sterol isomerase activity in yeast. J Biol Chem 1996;271: 22434-22440.
13. Carter C, Avenet P, Benavides J, et al. Ifenprodil and eliprodil: neuroprotective NMDA receptor antagonists and calcium channel blockers. In: Herrling PL, ed. Excitatory amino acids - clinical results with antagonists. San Diego: Academic Press, 1997:57-80.
14. Bottenstein JE, Sato GH. Growth of rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 1979;76:514-517.
15. Koenig HL, Schumacher M, Ferzaz B, et al. Progesterone synthesis and myelin formation by Schwann cells. Science 1995; 268:1500-1503.
16. Bass D, Bourbeau D, Sarlieve LL, Ittel ME, Dussault JH, Puymirat J. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormones. Glia 1997;19:324-332.
17. Tosic M, Torch S, Comte V, Dolivo M, Honegger P, Matthieu JM. Tri-iodotyronine has diverse and multiple stimulating effects on expression of the major myelin protein genes. J Neurochem 1992;59:1770-1777.
18. Solly S, Thomas JL, Monge M, et al. Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition. Glia 1996;18:39-48.
19. Bouchard P, Quirion R. 3H 1,3 di(2 tolyl)guanidine and 3H (-)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtype. Neuroscience 1997;76:467-477.
20. Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. TIPS 1997;18:67-70.
21. Itzhak Y, Stein I. Sigma binding sites in the brain; an emerging concept for multiple binding sites and their relevance for psychiatric disorders. Life Sci 1990;47:1073-1081.
22. Hanner M, Moebius FF, Flandorfer A, et al. Purification, molecular cloning and expression of the mammalian sigma-binding site. Proc Natl Acad Sci USA 1996;93:8072-8077.
23. Seth P, Fei YJ, Li HW, Huang W, Leibach FH, Ganapathy V. Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem 1998;70:922-931.
24. Prasad PD, Li HW, Fei Y-J, et al. Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 σ receptor gene. J Neurochem 1998;70:443-451.
25. Ozawa K, Suchanek G, Breischoff H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994;117: 1311-1322.
26. Lassmann H, Vaas K. Are current concepts of multiple sclerosis reflected by the immunopathology of its lesions? Springer Semin Immunopathol 1995;17:77-87.
27. Raine CS, Scheiberg L, Waltz JM. Multiple sclerosis: oligodendroglia survival and proliferation in an active established lesion. Lab Invest 1981;45:534-546.
28. Prineas JW, Barnard RO, Kwon LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993;33: 137-150.
29. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-399.
30. Trapp BD, Peterson J, Ransohof RM, Rudick R, Mörk S, Bö L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285.